1809 related articles for article (PubMed ID: 15289320)
21. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
23. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
25. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells.
Eligini S; Barbieri SS; Cavalca V; Camera M; Brambilla M; De Franceschi M; Tremoli E; Colli S
Cardiovasc Res; 2005 Feb; 65(3):683-93. PubMed ID: 15664395
[TBL] [Abstract][Full Text] [Related]
26. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
27. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
28. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
30. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
[TBL] [Abstract][Full Text] [Related]
31. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
[TBL] [Abstract][Full Text] [Related]
33. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
34. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
[TBL] [Abstract][Full Text] [Related]
35. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
36. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Won YK; Ong CN; Shi X; Shen HM
Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901
[TBL] [Abstract][Full Text] [Related]
37. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.
Pollmann C; Huang X; Mall J; Bech-Otschir D; Naumann M; Dubiel W
Cancer Res; 2001 Dec; 61(23):8416-21. PubMed ID: 11731421
[TBL] [Abstract][Full Text] [Related]
38. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
39. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
40. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
Zhong S; Quealy JA; Bode AM; Nomura M; Kaji A; Ma WY; Dong Z
Cancer Res; 2001 May; 61(10):4084-91. PubMed ID: 11358830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
